Fibrosing cholestatic hepatitis following cytotoxic chemotherapy for small-cell lung cancer

查看全文 作　　者：Jaime Ceballos-[1]Viro;José M López-[1]Picazo;José L Pérez-[1]Gracia;Jesús J [2]Sola;Gregorio [2]Aisa;Ignacio Gil-[1]Bazo

机构地区：[1]Department of Oncology,Clínica Universidad de Navarra,Pio XII 36,31008 Pamplona,Spain;[2]Department of Pathology,Clínica Universidad de Navarra,Pio XII 36,31008 Pamplona,Spain

出　　处：《World Journal of Gastroenterology》索引2009年第15卷第18期,共3页

摘　　要：Fibrosing cholestatic hepatitis(FCH) is a variant of viral hepatitis reported in hepatitis B virus or hepatitis C virus infected liver,renal or bone transplantation recipients and in leukemia and lymphoma patients after conventional cytotoxic chemotherapy.FCH constitutes a well-described form of fulminant hepatitis having extensive fibrosis and severe cholestasis as its most characteristic pathological findings.Here,we report a case of a 49-year-old patient diagnosed with small-cell lung cancer who developed this condition following conventional chemotherapy-induced immunosuppression.This is the first reported case in the literature of FCH after conventional chemotherapy for a solid tumor.In addition to a detailed report of the case,a physiopathological examination of this potentially life-threatening condition and its treatment options are discussed. 关键词：纤维化淤胆性肝炎小细胞肺癌细胞毒性化疗后丙型肝炎病毒感染乙型肝炎病毒常规化疗病毒性肝炎

相关文献

参考文献（17）
引证文献（3）
耦合文献（9）

参考文献(17)

引证文献(3)

耦合文献(9)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Fibrosing cholestatic hepatitis following cytotoxic chemotherapy for small-cell lung cancer

参考文献(17)

引证文献(3)

耦合文献(9)

用户提示